EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework

Bofang Yi, Sung Hun Bae, Yongzong Yang, Linda Jiang, Shirley Chen, Allesandra Stratigakis, Zhongyuan Zhao, Mohammad Asikur Rahman, Yanyan Li, Xinrui Sarea Wang, Peng Zou, Tao Zhang

Drug Metabolism and Disposition · 2026-05 · 54 (5) · 100271

DOI: 10.1016/j.dmd.2026.100271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-05. Verfasst von Bofang Yi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Binghamton University, State University of New York, Binghamton, New York. Hauptthemen laut MEDLINE: Milk, Human, Rivaroxaban, Pyrazoles, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of Women's Health, US Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk, HumanRivaroxabanPyrazolesModels, BiologicalPyridonesFactor Xa InhibitorsAnticoagulantsHumansFemaleInfantLactationInfant, NewbornAdultBiological Transport

Stichwörter der Autor:innen

Breast milk pharmacokineticsDrug permeability and efflux transportersInfant systemic exposureLactational drug transferMammary epithelial transportPhysiologically based pharmacokinetic modeling

Substanzen

RivaroxabanapixabanPyrazolesPyridonesFactor Xa InhibitorsAnticoagulants

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Binghamton University, State University of New York, Binghamton, New York.
  • Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York.
  • Department of Pharmacology, Department of Medicine-Cardiology Division, SUNY Upstate Medical University, Syracuse, New York.
  • Department of Nonclinical Development and Clinical Pharmacology, Ultragenyx Pharmaceutical Inc, Brisbane, California.
  • Department of Pharmaceutical Sciences, Binghamton University, State University of New York, Binghamton, New York. Electronic address: zhangt@binghamton.edu.

Förderung

  • Office of Women's Health
  • US Food and Drug Administration

Zitieren

APA

Yi, B., Bae, S. H., Yang, Y., Jiang, L., Chen, S., Stratigakis, A., Zhao, Z., Rahman, M. A., Li, Y., Wang, X. S., Zou, P., & Zhang, T. (2026). Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework. Drug Metabolism and Disposition, 54(5), 100271. https://doi.org/10.1016/j.dmd.2026.100271

Vancouver

Yi B, Bae SH, Yang Y, Jiang L, Chen S, Stratigakis A, et al. Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework. Drug Metabolism and Disposition. 2026;54(5):100271. doi:10.1016/j.dmd.2026.100271

BibTeX
@article{Yi2026,
  author = {Yi, Bofang and Bae, Sung Hun and Yang, Yongzong and Jiang, Linda and Chen, Shirley and Stratigakis, Allesandra and Zhao, Zhongyuan and Rahman, Mohammad Asikur and Li, Yanyan and Wang, Xinrui Sarea and Zou, Peng and Zhang, Tao},
  title = {Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  volume = {54},
  number = {5},
  pages = {100271},
  doi = {10.1016/j.dmd.2026.100271}
}
Kostenlos starten →